Papillary thyroid cancer (PTC) is a common endocrine malignancy that frequently harbors the
oncogenic T1799A BRAF mutation. As a novel prognostic molecular marker, this mutation …

… outcomes in thyroid cancer patients. In … prognostic utility in some tumor types. To our
knowledge, no previous studies have evaluated this panel of molecular markers in thyroid cancer, …

… The prognostic utility of these two systems converges when additional demographic and
clinical factors are considered. AJCC staging was found to classify patients across a wider …

… rearrangement in inflammatory and benign lesions and the low prevalence of RET/PTC
rearrangements in sporadic thyroid cancer, almost everybody agrees that RET/PTC utility as a …

… To illustrate the impact of age and utility of the nomogram designed for this study, we present
a hypothetical patient with MTC. A 71-year old non-Hispanic white female with a T3N1M0 …

… diagnostic tool, some investigating its utility as a prognostic marker, and others simply
assessing feasibility of cfDNA measurement in thyroid cancer. There was also significant variation …

… utilities obtained from clinicians caring for thyroid cancer … Rather than obtaining values for
these 2 utilities from a … each patient's preferences regarding thyroid hormone dependency and …

… Because thyroid cancer often presents as an incidental thyroid nodule, current diagnostic
pathways … Surgical utility of Afirma: effects of high cancer prevalence and oncocytic cell types in …

… To note, some studies have suggested that preoperative TG levels may be more predictive
in follicular cancer as compared to papillary thyroid cancer, but as these contributed a …

… From these studies, the clinical utility of miRNA expression determination in cancer tissues
also emerged, as they were found to be significantly associated with diagnosis, prognosis, …